Liu Binkai, Zong Geng, Zhu Lu, Hu Yang, Manson JoAnn E, Wang Molin, Rimm Eric B, Hu Frank B, Sun Qi
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
BMJ. 2024 Dec 4;387:e078386. doi: 10.1136/bmj-2023-078386.
To prospectively investigate the associations between dark, milk, and total chocolate consumption and risk of type 2 diabetes (T2D) in three US cohorts.
Prospective cohort studies.
Nurses' Health Study (NHS; 1986-2018), Nurses' Health Study II (NHSII; 1991-2021), and Health Professionals Follow-Up Study (HPFS; 1986-2020).
At study baseline for total chocolate analyses (1986 for NHS and HPFS; 1991 for NHSII), 192 208 participants without T2D, cardiovascular disease, or cancer were included. 111 654 participants were included in the analysis for risk of T2D by intake of chocolate subtypes, assessed from 2006 in NHS and HPFS and from 2007 in NHSII.
Self-reported incident T2D, with patients identified by follow-up questionnaires and confirmed through a validated supplementary questionnaire. Cox proportional hazards regression was used to estimate hazard ratios and 95% confidence intervals (CIs) for T2D according to chocolate consumption.
In the primary analyses for total chocolate, 18 862 people with incident T2D were identified during 4 829 175 person years of follow-up. After adjusting for personal, lifestyle, and dietary risk factors, participants consuming ≥5 servings/week of any chocolate showed a significant 10% (95% CI 2% to 17%; P trend=0.07) lower rate of T2D compared with those who never or rarely consumed chocolate. In analyses by chocolate subtypes, 4771 people with incident T2D were identified. Participants who consumed ≥5 servings/week of dark chocolate showed a significant 21% (5% to 34%; P trend=0.006) lower risk of T2D. No significant associations were found for milk chocolate intake. Spline regression showed a linear dose-response association between dark chocolate intake and risk of T2D (P for linearity=0.003), with a significant risk reduction of 3% (1% to 5%) observed for each serving/week of dark chocolate consumption. Intake of milk, but not dark, chocolate was positively associated with weight gain.
Increased consumption of dark, but not milk, chocolate was associated with lower risk of T2D. Increased consumption of milk, but not dark, chocolate was associated with long term weight gain. Further randomized controlled trials are needed to replicate these findings and further explore the mechanisms.
前瞻性研究美国三个队列中黑巧克力、牛奶巧克力和总巧克力摄入量与2型糖尿病(T2D)风险之间的关联。
前瞻性队列研究。
护士健康研究(NHS;1986 - 2018年)、护士健康研究II(NHSII;1991 - 2021年)和卫生专业人员随访研究(HPFS;1986 - 2020年)。
在总巧克力分析的研究基线时(NHS和HPFS为1986年;NHSII为1991年),纳入了192208名无T2D、心血管疾病或癌症的参与者。根据巧克力亚型摄入量分析T2D风险时纳入了111654名参与者,NHS和HPFS从2006年开始评估,NHSII从2007年开始评估。
自我报告的新发T2D,通过随访问卷识别患者,并通过经过验证的补充问卷进行确认。采用Cox比例风险回归根据巧克力摄入量估计T2D的风险比和95%置信区间(CI)。
在总巧克力的主要分析中,在4829175人年的随访期间识别出18862例新发T2D患者。在调整个人、生活方式和饮食风险因素后,与从不或很少食用巧克力的人相比,每周食用≥5份任何巧克力的参与者患T2D的发生率显著降低10%(95%CI 2%至17%;P趋势 = 0.07)。在按巧克力亚型进行的分析中,识别出4771例新发T2D患者。每周食用≥5份黑巧克力的参与者患T2D的风险显著降低21%(5%至34%;P趋势 = 0.006)。未发现牛奶巧克力摄入量与T2D之间存在显著关联。样条回归显示黑巧克力摄入量与T2D风险之间存在线性剂量反应关系(线性P值 = 0.003),每周每食用一份黑巧克力,观察到风险显著降低3%(1%至5%)。牛奶巧克力摄入量与体重增加呈正相关,但黑巧克力摄入量与体重增加无关。
增加黑巧克力而非牛奶巧克力的摄入量与较低的T2D风险相关。增加牛奶巧克力而非黑巧克力的摄入量与长期体重增加相关。需要进一步的随机对照试验来重复这些发现并进一步探索其机制。